Philip Morris International Reports Q2 2025 Results: Revenue Reaches $10.14 Billion as Smoke-Free Products Rise to 41% of Total Sales

Jul.22.2025
Philip Morris International Reports Q2 2025 Results: Revenue Reaches $10.14 Billion as Smoke-Free Products Rise to 41% of Total Sales
On July 22, Philip Morris International (PMI) reported Q2 2025 earnings with net revenue of $10.14 billion, up 7.1% year-over-year. Smoke-free product revenue reached $4.2 billion (41% of total), growing 14.5% organically. Heated tobacco shipments hit 38.8 billion units; e-vapor shipments more than doubled; nicotine pouch volume rose 43.3%. IQOS market share in Japan climbed to 31.7%. PMI raised its full-year EPS guidance to $7.24–$7.37.

Philip Morris International (PMI) reported robust financial results for the second quarter of 2025, with total net revenues reaching $10.14 billion, a 7.1% increase compared to the same period last year. Adjusted diluted earnings per share (EPS) rose 20.1% to $1.91, while reported diluted EPS increased 26.6% to $1.95.

 

The company’s smoke-free product (SFP) segment delivered particularly strong performance, with net revenues up 15.2% and gross profit rising 23.3%. Despite a 1.5% decline in combustible cigarette shipments, revenue from the combustibles segment grew 2.1%, driven by effective pricing strategies. Gross profit from combustibles rose 5.0%.

 

PMI declared a quarterly dividend of $1.35 per share, or $5.40 on an annualized basis, and raised its full-year earnings guidance. The company now expects adjusted diluted EPS to grow between 13% and 15% for the full year 2025.

 

Key Q2 2025 Figures

Net revenues: $10.14 billion (+7.1% YoY)

Reported diluted EPS: $1.95 (+26.6%)

Adjusted diluted EPS: $1.91 (+20.1%)

Smoke-free product revenue: $4.2 billion (+15.2%, 41% of total)

Combustible product revenue: $6.0 billion (+2.1%)

Operating income: $3.71 billion (+7.8%)

Quarterly dividend: $1.35 per share (annualized: $5.40)

 

Smoke-Free Product Highlights

PMI’s smoke-free portfolio accounted for 41% of net revenues and over 42% of gross profit. Shipment volume rose 11.8% from a year ago. IQOS, PMI’s flagship heat-not-burn product, surpassed $3 billion in quarterly revenues and reached a 9.2% share of global cigarette and HTU volumes.

 

IQOS HTU shipment volume reached 38.8 billion units (+9.2% YoY), with adjusted market share in Japan rising to 31.7%, and in Europe to 10.9%.

 

Nicotine pouch shipments rose to 214.7 million cans globally (+43.3%), including 191.3 million in the Americas. Snus shipments totaled 59.6 million cans (+1.4%).

 

VEEV, PMI’s e-vapor brand, more than doubled its global shipment volume. It is now sold in 42 markets and ranks first in closed-pod sales in six European countries, including Greece and Italy.

 

Combustibles Segment

Cigarette shipments declined 1.5% to 155.2 billion units. However, revenue in this segment grew 2.1%, supported by favorable pricing. Gross profit increased 5.0%.

 

Regional Performance

Europe: shipment volume down 1.7%, smoke-free shipments up 11.7%

Southeast Asia, CIS, Middle East: shipments up 1.2%, smoke-free up 14.8%

East Asia, Australia, and Global Travel Retail: shipments up 4.1%, smoke-free up 7.2%

Americas: shipments up 6.2%, smoke-free up 30.2%

 

Outlook

PMI reaffirmed its commitment to transitioning away from combustible tobacco. The company aims to reduce cigarette volumes and accelerate adoption of smoke-free alternatives across markets.

 

For full-year 2025, PMI forecasts adjusted diluted EPS of $7.43 to $7.56, representing growth of 13% to 15%. It expects organic net revenue to grow 6% to 8% and smoke-free product shipments to rise by 12% to 14%.

 

JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI nicotine pouch brand Nordic Spirit has entered a long-term partnership with Manchester’s Co-op Live, becoming the venue’s Official Nicotine Pouch Partner. The 23,500-capacity venue is the UK’s largest indoor live entertainment arena. Nordic Spirit will run in-venue activations for existing adult nicotine consumers and sell products at selected arena bars. The agreement was entered into before the relevant UK sponsorship restrictions were introduced, while the government intends to implement a comprehensive ban on advertising and sponsorship of vaping and nicotine products from June 1, 2027.
Sep.07
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan Industrial Co., Ltd. has filed a patent application for a cellulose-free scaffold material for nicotine pouches, proposing a combination of bioceramic material, polydextrose and sugar alcohols to replace conventional microcrystalline cellulose and cellulose derivatives. The filing aims to address issues including powdery mouthfeel, residue and limited release control, while also reducing reliance on existing cellulose-based patent portfolios. In patent examples, one fast-release formulation reached a nicotine release rate of 50% at 10 minutes and more than 90% at 20 minutes.
Sep.02
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea's Constitutional Court has upheld fixed taxes on nicotine-containing e-cigarette liquids based on solution volume, ruling that challenged provisions imposing KRW 370 per milliliter in individual consumption tax and KRW 628 per milliliter in tobacco consumption tax do not violate the Constitution. The cases stemmed from historical disputes involving importers that reported nicotine as being extracted from tobacco stems rather than leaves. South Korea has since broadened its tobacco definition to include synthetic nicotine, while current tax laws provide reduced rates for certain products not derived from tobacco.
Sep.18
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives